0 likes | 5 Views
The surge in demand for precise genetic profiling is largely driven by the rise of personalized medicine and targeted drug development. Pharmaceutical companies are leveraging gene expression technologies for biomarker identification, patient stratification, and treatment response monitoring.
E N D